Susanne B. Haga

Associate Research Professor of Biology

101 Science Drive, Box 3382 CIEMAS Suite 2121, Durham, NC 27708
Campus Box: 
101 Science Drive - CIEMAS Bldg, Box 3382, Durham, NC 27708
(919) 684-0325
My research interests focus on issues affecting the translation of genomics to clinical practice. Specifically, I have a strong interest in education, with each of my research projects involving some component of professional, public or patient education, including development of educational materials about genomic research in general, pharmacogenetic testing, and communicating genetic test results, in addition to undergraduate teaching in genetics/genomics, ethics, and policy. Areas of expertise: Bioethics and Health Behavior


  • Ph.D., University of Maryland - Baltimore 1999

Ginsburg, G. S., and S. B. Haga. “Foundations and application of precision medicine.” In Emery and Rimoin’s Principles and Practice of Medical Genetics and Genomics: Foundations, 21–45, 2018. Full Text

Haga, S. B. “Precision Medicine and Challenges in Research and Clinical Implementation.” In Principles of Gender-Specific Medicine: Gender in the Genomic Era: Third Edition, 717–32, 2017. Full Text

Haga, S. B. “Overview of Policy, Ethical, and Social Considerations in Genomic and Personalized Medicine.” In Genomic and Precision Medicine: Primary Care: Third Edition, 19–43, 2017. Full Text

Haga, S. B. “Genome Policy Considerations for Genomic Medicine.” In Essentials of Genomic and Personalized Medicine, 209–22, 2010. Full Text

Haga, S. B. “From Sequence to Genomic Medicine: Genome Policy Considerations.” In Genomic and Personalized Medicine, Two-Vol Set, 387–400, 2009. Full Text

Haga, Susanne B. “Managing Increased Accessibility to Pharmacogenomic Data.Clin Pharmacol Ther 106, no. 5 (November 2019): 922–24. Full Text

Weitzel, Kristin Wiisanen, Benjamin Q. Duong, Meghan J. Arwood, Aniwaa Owusu-Obeng, Noura S. Abul-Husn, Barbara A. Bernhardt, Brian Decker, et al. “A stepwise approach to implementing pharmacogenetic testing in the primary care setting.Pharmacogenomics 20, no. 15 (October 2019): 1103–12. Full Text

Villegas, Catalina, and Susanne B. Haga. “Access to Genetic Counselors in the Southern United States.J Pers Med 9, no. 3 (July 1, 2019). Full Text

Haga, Susanne B., and Jivan Moaddeb. “Pharmacogenomics courses in pharmacy school curricula.Pharmacogenomics 20, no. 9 (June 2019): 625–30. Full Text

Haga, Susanne B., Esther Kim, Rachel A. Myers, and Geoffrey S. Ginsburg. “Primary Care Physicians' Knowledge, Attitudes, and Experience with Personal Genetic Testing.J Pers Med 9, no. 2 (May 24, 2019). Full Text

Wu, R Ryanne, Rachel A. Myers, Adam H. Buchanan, David Dimmock, Kimberly G. Fulda, Irina V. Haller, Susanne B. Haga, et al. “Effect of Sociodemographic Factors on Uptake of a Patient-Facing Information Technology Family Health History Risk Assessment Platform.Appl Clin Inform 10, no. 2 (March 2019): 180–88. Full Text

Madhavan, Sarina, Emily Bullis, Rachel Myers, Chris J. Zhou, Elise M. Cai, Anu Sharma, Shreya Bhatia, Lori A. Orlando, and Susanne B. Haga. “Awareness of family health history in a predominantly young adult population.Plos One 14, no. 10 (2019): e0224283. Full Text


Selected Grants

Building and Deploying a Genomic-Medicine Risk Assessment Model for Diverse Primary Care Populations. awarded by National Institutes of Health (Investigator). 2018 to 2023

Summer Scholars Program in Genome Sciences and Medicine awarded by National Institutes of Health (Principal Investigator). 2017 to 2022

Postdoctoral Training in Genomic Medicine Research awarded by National Institutes of Health (Co-Principal Investigator). 2017 to 2022

IRES Track 1 IRTG Engaged in Dissecting and Reengineering the Regulatory Genome awarded by National Science Foundation (Associate Director). 2019 to 2022

Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health (Principal Investigator). 2011 to 2020

VGER, The Vanderbilt Genome-Electronic Records Project awarded by (Investigator). 2018 to 2019

IPA -Rachel Mills awarded by (Principal Investigator). 2019

Genetic Risk Testing & Health Coaching for T2D and CHD awarded by Air Force Office of Scientific Research (Co Investigator). 2013 to 2017

Pharmacogenetic Testing: Challenges of Clinical Integration awarded by National Institutes of Health (Principal Investigator). 2007 to 2015